Authors: LEYTON M BELANGER C MARTIAL J BEAULIEU S CORIN E PECKNOLD J KIN NMKNY MEANEY M THAVUNDAYIL J LARUE S NAIR NPV

Citation: M. Leyton et al., CARDIOVASCULAR, NEUROENDOCRINE, AND MONOAMINERGIC RESPONSES TO PSYCHOLOGICAL STRESSORS - POSSIBLE DIFFERENCES BETWEEN REMITTED PANIC DISORDER PATIENTS AND HEALTHY CONTROLS, Biological psychiatry, 40(5), 1996, pp. 353-360

Authors: PECKNOLD J LUTHE L MUNJACK D ALEXANDER P

Citation: J. Pecknold et al., A DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY WITH ALPRAZOLAMAND EXTENDED-RELEASE ALPRAZOLAM IN THE TREATMENT OF PANIC DISORDER, Journal of clinical psychopharmacology, 14(5), 1994, pp. 314-321

Authors: INY LJ PECKNOLD J SURANYICADOTTE BE BERNIER B LUTHE L NAIR NPV MEANEY MJ

Citation: Lj. Iny et al., STUDIES OF A NEUROCHEMICAL LINK BETWEEN DEPRESSION, ANXIETY, AND STRESS FROM [H-3] IMIPRAMINE AND [H-3] PAROXETINE BINDING ON HUMAN PLATELETS, Biological psychiatry, 36(5), 1994, pp. 281-291

Authors: BALLENGER JC PECKNOLD J RICKELS K SELLERS EM",SCHATZBERG,"SHADER RI",SHEAR,WEISSMAN

Citation: Jc. Ballenger et al., MEDICATION DISCONTINUATION IN PANIC DISORDER, The Journal of clinical psychiatry, 54, 1993, pp. 15-24

Authors: PECKNOLD J ALEXANDER PE MUNJACK D

Citation: J. Pecknold et al., ALPRAZOLAM-XR IN THE MANAGEMENT OF ANXIETY - DISCONTINUATION, Psychiatric annals, 1993, pp. 38-44